Bayer achieves 98.3% take-up for rights issue
Bayer, the German pharmaceuticals giant, has completed its jumbo €6bn rights issue with 98.3% of shareholders taking up their rights.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: